The American Diabetes Association® (ADA) welcomes Rita Rastogi Kalyani, MD, MHS, whose appointment as its new chief scientific and medical officer was previously announced, as she begins her tenure at the organization. In this role, Dr. Kalyani will lead the ADA’s efforts in diabetes prevention, health care improvement, research and science, nutrition and wellness, and obesity education and prevention. Her work will also encompass community engagement and diabetes self-management education as part of the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Dr. Kalyani brings over 15 years of experience in the field of endocrinology, and in recognition of her dedication to public awareness in support of the field, she was the recipient of the Endocrine Society’s Laureate Award for Outstanding Public Service in 2022.
"We are thrilled to officially welcome Dr. Kalyani to the ADA,” said Charles "Chuck" Henderson, the ADA’s chief executive officer. “Under her leadership, I am confident that the ADA will continue to drive measurable impact and transformational change for everyone affected by diabetes and obesity.”
For media inquiries or interview opportunities with Dr. Kalyani, please contact press@.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
